Skip to main content
Equibles
ACIU logo

ACIU · AC Immune SA

Track ACIU — free

Use ACIU with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.96 +0.12 (+4.23%)
Rebalance outlook locked
Market Cap
$282.37M
Shares
99.43M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
3.57M -86.9%
FY2025 Revenue FY2015–FY2025
Net Income
-70.45M -38.4%
FY2025 Net Income FY2015–FY2025
Operating Margin
-1940.05% -1748.2pp
FY2025 Operating Margin FY2015–FY2025
Operating Cash Flow
-69.26M -205.2%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
CHF 3.57M 27.31M 14.8M 3.94M 0 15.43M 110.46M 6.91M 20.26M 23.21M 39.09M
CHF 56.44M 62.57M 54.61M 60.34M 62.28M 59.49M 50.43M 44.28M 32.66M 25.77M 17.05M
CHF 16.09M 17.26M 15.31M 15.79M 17.91M 18.56M — — — — —
CHF 1.39M 1.49M 1.67M 1.79M 1.9M 1.54M 1.27M 961K 580K 278K 287K
CHF -69.32M -52.38M -53.62M -70.85M -79.01M -61.26M 44.54M -49.55M -22.54M -10.46M 18.62M
CHF 191K 133K 176K 355K 581K 184K 1.93M 334K — — —
CHF -70.45M -50.91M -54.22M -70.74M -72.99M -61.92M 45.44M -50.95M -26.41M -7.1M 20.27M
CHF 0 3000 10K 13K 3000 0 0 0 0 0 0
CHF -70.45M -50.92M -54.23M -70.75M -73M -61.92M 45.44M -50.95M -26.41M -7.1M 20.27M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2018–FY2022: $100K in buybacks.

Key facts CIK 1651625 CUSIP H00263105 13F (30d) 36 filings 36 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)